When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ZGNX - Zogenix's Fintepla wins European nod for rare childhood epilepsy
Zogenix Inc.
The European Commission approves Zogenix's ([[ZGNX]] -0.8%) Fintepla (fenfluramine) oral solution for the treatment of seizures associated with Dravet syndrome as an add-on therapy to other anti-epileptic medicines for patients two years of age and older.First EU market launch planned for Germany in Q1 2021.Fintepla was approved in the U.S. in June this year.